MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    The frequency of glucocerebrosidase mutations in a subgroup of early-onset Parkinson’s disease patients in the Korean population

    J. Lee, J. Hwangbo (Yangsan, Republic of Korea)

    Objective: We investigated the frequency of GBA mutations in the Korean patients with early-onset Parkinson’s disease (PD). Background: Glucocerebrosidase (GBA) mutations are associated with increased…
  • 2022 International Congress

    Motor resonance flexibility to emotion-enriched context in Parkinson’s disease patients with and without freezing of gait.

    E. Pelosin, G. Lagravinese, A. Bisio, M. Bove, A. Botta, G. Bonassi, R. Marchese, S. Mezzarobba, P. Ruggeri, L. Avanzino (Genova, Italy)

    Objective: This study aims at exploring the response of the mirror neuron system, specifically motor resonance, to an emotion-enriched context in people with Parkinson disease…
  • 2022 International Congress

    Characterization of gastrointestinal dysfunction in Parkinson’s by disease stage

    M. Camacho, J. Greenland, D. Apostolopoulos, C. Daruwalla, C. Williams-Gray (Cambridge, United Kingdom)

    Objective: To conduct a comprehensive cross-sectional and longitudinal characterization of gastrointestinal dysfunction (GID) in Parkinson’s disease (PD). Background: GID is an important feature of PD…
  • 2022 International Congress

    Can we add whey protein supplementation in patients with Parkinson’s disease without interfering with levodopa response?

    G. Pinelli, C. Siri, A. Ranghetti, V. Cereda, R. Maestri, M. Canesi (Gravedona, Italy)

    Objective: The main endpoint of the study was to evaluate if a daily intake of whey protein-based dietary supplement causes a worse response to levodopa…
  • 2022 International Congress

    Scaling the Roche Digital Health Technology Platform to Assess Disease Severity and Progression in Individuals with Parkinson’s Disease

    W. Popp, K. Taylor, A. Bamdadian, L. Restelli, J. Schjodt-Eriksen, G. Pagano, H. Svoboda, A. Bonni, M. Lindemann (Basel, Switzerland)

    Objective: Here we present the development of a novel platform to deliver the Roche Parkinson’s Disease (PD) Mobile Application to researchers to actively measure motor…
  • 2022 International Congress

    Boostering motor imagery processing to improve gait in patients with Parkinson disease and freezing of gait: a preliminary study

    S. Mezzarobba, E. Ravizzotti, P. Bernardis, M. Putzolu, C. Cosentino, A. Botta, G. Bonassi, R. Marchese, L. Avanzino, E. Pelosin (Genoa, Italy)

    Objective: The aim of this study is to evaluate the priming effect of visual, auditory and cognitive tasks in enhancing Motor Imagery (MI) ability in…
  • 2022 International Congress

    Performance of oral diadochokinesis in Parkinson’s Disease motor subtypes

    V. Dos Santos, R. Rothe-Neves,, A. Bressanelli, I. Klein, M. Olchik (Porto Alegre, Brazil)

    Objective: To compare the performance of the oral diadochokinesis task in the different motor subtypes of PD (postural instability/gait difficulty - PIGD, tremor-dominant - TD,…
  • 2022 International Congress

    Pilot study to investigate the use of in-clinic sensing to identify optimal stimulation parameters for deep brain stimulation therapy in Parkinson’s disease

    S. Lewis, S. Ojemann, D. Kramer, L. Hirt, E. Radcliffe, M. Case, A. Becker, R. Raike, J. Thompson, D. Kern (Boulder, USA)

    Objective: Compare the use of in-clinic sensing functionality and standard of care monopolar review for identifying optimal settings of a deep brain stimulation (DBS) in…
  • 2022 International Congress

    Parkin deficiency impairs mtDNA dynamics and propagates inflammation

    K. Wasner, S. Smajić, J. Ghelfi, S. Delcambre, C. Prada-Medina, E. Knappe, G. Arena, P. Mulica, G. Agyeah, A. Rakovic, I. Boussaad, K. Badanjak, J. Ohnmacht, J. Gérardy, M. Takanashi, J. Trinh, M. Mittelbronn, N. Hattori, C. Klein, P. Antony, P. Seibler, M. Spielmann, S. Pereira, A. Grünewald (Belvaux, Luxembourg)

    Objective: We sought to explore Parkin’s role in (i) averting neuronal mtDNA dyshomeostasis/release and (ii) the activation of downstream inflammatory processes. Background: Mutations in Parkin…
  • 2022 International Congress

    Challenges in Outcome Measure Selection in Multi-Arm Multi-Stage Clinical Trials in Parkinson Disease

    C. Gonzalez-Robles, M. Bartlett, M. Burnell, R. Chapman, R. Chaudhuri, C. Clarke, R. Ellis-Doyle, M. Hu, B. Huxford, A. Jha, M. Lawton, G. Mills, A. Noyce, P. Piccini, L. Rochester, J. Rudiger, C. Siu, D. van Wamelen, C. Williams-Gray, ML. Zeissler, H. Zetterberg, C. Carroll, T. Foltynie, R. Weil, A. Schrag (London, United Kingdom)

    Objective: The Edmond J Safra Accelerating Clinical Trials in Parkinson Disease (PD) initiative (EJS ACT-PD) aims to accelerate the identification of disease modifying treatment for…
  • « Previous Page
  • 1
  • …
  • 253
  • 254
  • 255
  • 256
  • 257
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley